Japanese Trademark — JPO

2025363089

Application 2025363089 · 00

Quick Facts

Application Number	2025363089
Registration Number	1881620
Status	00
Mark Type	madrid
Owner	AB MAvatar
Filed	2025-10-16
Registered	2025-09-10

Is this trademark active?

2025363089 has a current status of 00.

Goods & Services

The specification below is taken directly from the filed record at the Japan Patent Office for each Nice class this trademark covers.

Class 9 — Electrical & IT

Downloadable software; downloadable software for medical diagnostics; databases; downloadable artificial intelligence software that integrates model data with biomedical data of patients to create a digital twin of a patient; downloadable artificial intelligence software that integrates model data with biomedical data to create a digital twin of a patient; downloadable software for research and analysis of medical and biomedical data; downloadable software for gathering, compiling, analyzing, authenticating, validating, controlling, protecting, exchanging, and modifying genetic, genomic, molecular, and biomarker data; downloadable software for comparing patient biomarker data against genetic, proteomic, and transcriptomic database; downloadable software for pharmaceutical companies and healthcare providers; downloadable software for developing drugs by simulating patient responses to medications; downloadable software for predicting patient treatment response; databases containing biomedical data.

Class 42 — Scientific & IT Services

Research and development services; biomedical research services; platform as a service; software as a service; platforms for artificial intelligence as software as a service featuring software that integrates model data with biomedical data of patients to create a digital twin of a patient; software as a service that integrates model data with biomedical data of a patient to create a digital twin of a patient; platforms for artificial intelligence as software as a service featuring software that integrates model data with biomedical data to create a digital twin of a patient; software as a service that integrates model data with biomedical data to create a digital twin of a patient; platforms for artificial intelligence as software as a service for research and analysis of medical and biomedical data; software as a service for research and analysis of medical and biomedical data; platforms for artificial intelligence as software as a service for gathering, compiling, analyzing, authenticating, validating, controlling, protecting, exchanging, and modifying genetic, genomic, molecular and biomarker data; software as a service for gathering, compiling, analyzing, authenticating, validating, controlling, protecting, exchanging and modifying genetic, genomic, molecular and biomarker data; platforms for artificial intelligence as software as a service for comparing patient biomarker data against genetic, proteomic, and transcriptomic database; software as a service for comparing patient biomarker data against genetic, proteomic, and transcriptomic database; platforms for artificial intelligence as software as a service for pharmaceutical companies and healthcare providers; software as a service for pharmaceutical companies and healthcare providers; platforms for artificial intelligence as software as a service for developing drugs by simulating patient responses to medications; software as a service for developing drugs by simulating patient responses to medications; platforms for artificial intelligence as software as a service for predicting patient treatment response; software as a service for predicting patient treatment response; information services relating to research; information services relating to pharmaceutical drug development; information services provided via the internet, namely providing information to pharmaceutical companies to streamline drug discovery and development; providing scientific analysis and informational reports based upon results of genetic, genomic, molecular, and biomarker data.

Class 44 — Medical & Beauty Services

Healthcare information services; healthcare consultancy services; healthcare services; medical information services provided via the internet, namely providing personalized treatment suggestions to medical professionals tailored after their patients' health profile; medical information services provided via the internet, namely providing medical information to pharmaceutical companies to streamline drug discovery and development; provision of medical information from online databases.

Applicant

Name (romanised)

AB MAvatar

Timeline

Filed: 2025-10-16
Registered: 2025-09-10

About This Trademark

This device mark (application number 2025363089) is a 00 trademark on the Japan Patent Office register, filed by AB MAvatar on 16 October 2025, with registration granted on 10 September 2025.

This mark is recorded under multiple classes: Class 9 (scientific, electrical & IT apparatus); Class 42 (scientific, IT & design services); Class 44 (medical, veterinary & beauty services), specifically covering: Downloadable software; downloadable software for medical diagnostics; databases; downloadable artificial intelligence software that integrates model data with biomedical data of patients to create a digital twin of a patient; downloadable artificial intelligence software that integrates model data with biomedical data to create a digital twin of a patient; downloadable software for research and analysis of medical and biomedical data; downloadable software for gathering, compiling, analyzing, authenticating, validating, controlling, protecting, exchanging, and modifying genetic, genomic, molecular, and biomarker data; downloadable software for comparing patient biomarker data against genetic, proteomic, and transcriptomic database; downloadable software for pharmaceutical companies and healthcare providers; downloadable software for developing drugs by simulating patient responses to medications; downloadable software for predicting patient treatment response; databases containing biomedical data.; Research and development services; biomedical research services; platform as a service; software as a service; platforms for artificial intelligence as software as a service featuring software that integrates model data with biomedical data of patients to create a digital twin of a patient; software as a service that integrates model data with biomedical data of a patient to create a digital twin of a patient; platforms for artificial intelligence as software as a service featuring software that integrates model data with biomedical data to create a digital twin of a patient; software as a service that integrates model data with biomedical data to create a digital twin of a patient; platforms for artificial intelligence as software as a service for research and analysis of medical and biomedical data; software as a service for research and analysis of medical and biomedical data; platforms for artificial intelligence as software as a service for gathering, compiling, analyzing, authenticating, validating, controlling, protecting, exchanging, and modifying genetic, genomic, molecular and biomarker data; software as a service for gathering, compiling, analyzing, authenticating, validating, controlling, protecting, exchanging and modifying genetic, genomic, molecular and biomarker data; platforms for artificial intelligence as software as a service for comparing patient biomarker data against genetic, proteomic, and transcriptomic database; software as a service for comparing patient biomarker data against genetic, proteomic, and transcriptomic database; platforms for artificial intelligence as software as a service for pharmaceutical companies and healthcare providers; software as a service for pharmaceutical companies and healthcare providers; platforms for artificial intelligence as software as a service for developing drugs by simulating patient responses to medications; software as a service for developing drugs by simulating patient responses to medications; platforms for artificial intelligence as software as a service for predicting patient treatment response; software as a service for predicting patient treatment response; information services relating to research; information services relating to pharmaceutical drug development; information services provided via the internet, namely providing information to pharmaceutical companies to streamline drug discovery and development; providing scientific analysis and informational reports based upon results of genetic, genomic, molecular, and biomarker data.; Healthcare information services; healthcare consultancy services; healthcare services; medical information services provided via the internet, namely providing personalized treatment suggestions to medical professionals tailored after their patients' health profile; medical information services provided via the internet, namely providing medical information to pharmaceutical companies to streamline drug discovery and development; provision of medical information from online databases.

Frequently Asked Questions

Is Japanese trademark 2025363089 currently a registered trademark?

No — the Japan Patent Office records the status of Japanese trademark 2025363089 as 00.

Which Nice classes is Japanese trademark 2025363089 registered under?

Japanese trademark 2025363089 is recorded in Class 9 (scientific, electrical & IT apparatus); Class 42 (scientific, IT & design services); Class 44 (medical, veterinary & beauty services). The filed specification reads: Class 9: Downloadable software; downloadable software for medical diagnostics; databases; downloadable artificial intelligence software that integrates model data with biomedical data of patients to create a digital twin of a patient; downloadable artificial intelligence software that integrates model data with biom…

When was Japanese trademark 2025363089 filed?

Japanese trademark 2025363089 was filed at the Japan Patent Office on 16 October 2025 and registered on 10 September 2025.

Data Source

Japan (Japan Patent Office)

Japanese trademark data is supplied by the Japan Patent Office (JPO) via the JPO open bulk data release. Official government publications in Japan are not subject to copyright under Article 13 of the Japanese Copyright Act. Local copy last synchronised on 2026-04-25.

The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.